Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 24, 2026
Q4 2025
Q3 2025
Nov 6, 2025